Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy

Retina

Volumn 31, Issue 6, 2011, Pages 1137-1142

  Chen, Weiqi ^a   Chen, Haoyu ^a   Hou, Ping ^a   Fok, Andrew ^a   Hu, Yijun ^a   Lam, Dennis S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Proliferative vitreoretinopathy; silicone oil; triamcinolone; vitrectomy

Indexed keywords

SILICONE OIL; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENDOTAMPONADE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY;

ADULT; AGED; DRAINAGE; ENDOTAMPONADE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; PHACOEMULSIFICATION; RETROSPECTIVE STUDIES; SILICONE OILS; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY; YOUNG ADULT;

EID: 79958295846     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181fe5427     Document Type: Article

References (29)

1. Sun JK, Arroyo JG. Adjunctive therapies for proliferative vitreoretinopathy. Int Ophthalmol Clin 2004;44:1-10. (Pubitemid 38955656)
2. Young TA, D'Amico DJ. Controversies in proliferative vitreoretinopathy tamponade and pharmacologic adjuvants. Int Ophthalmol Clin 2005;45:163-171. (Pubitemid 41546832)
3. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979;77:171-180. (Pubitemid 10072805)
4. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90:810-816. (Pubitemid 11199134)
5. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000;84:1064-1067.
6. Munir WM, Pulido JS, Sharma MC, Buerk BM. Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Can J Ophthalmol 2005;40:598-604. (Pubitemid 41564963)
7. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 2001;29:2-6. (Pubitemid 32170788)
8. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection oftriamcinolone acetonide. Br J Ophthalmol 2003;87:24-27. (Pubitemid 36071773)
9. Lam DS, Chan CK, Mohamed S, et al. A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema. Br J Ophthalmol 2007;91: 199-203. (Pubitemid 46202869)
10. Cunningham MA, Edelman JL, Kaushal S. Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol 2008;53:139-149. (Pubitemid 351391933)
11. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121-125.
12. Chen JC. Sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol 1996;114:1273-1275. (Pubitemid 26338863)
13. Cheema RA, Peyman GA, Fang T, Jones A, Lukaris AD, Lim K. Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretin-opathy. Ophthalmic Surg Lasers Imaging 2007;38:365-370. (Pubitemid 350057916)
14. Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology 2008;115: 1938-1943.
15. Olson JA, Steffensen EH, Margulis RR, Smith RW, Whitney EL. Effect of ACTH on certain inflammatory diseases of the eye. JAMA 1950;142:1276-1278.
16. Woods AC Clinical and experimental observations on the use of ACTH and cortisone in ocular inflammatory disease. Am J Ophthalmol 1950;33:1325-1349.
17. Degenring RF, Jonas JB. Intravitreal injection oftriamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 2003;87:361. (Pubitemid 36307916)
18. Chan CK, Chan WM, Cheung BT, Yuen CY, Lee VY, Lam DS. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2004;122:1083-1085; author reply 6-8.
19. Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcino-lone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol 2006;90:337-341. (Pubitemid 43325467)
20. Ueno A, Enaida H, Hata Y, et al. Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study. Eur J Ophthalmol 2007;17:392-398. (Pubitemid 47056296)
21. Spitzer MS, Kaczmarek RT, Yoeruek E, et al. The distribution, release kinetics, and biocompatibility oftriamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci 2009; 50:2337-2343.
22. Pastor JC, Del Nozal MJ, Zamarron E, Garcia M. Solubility of triamcinolone acetonide and other anti-inflammatory drugs in silicone oil: implications for Therapeutic Efficacy. Retina 2008;28:1247-1250.
23. Jonas JB. Concentration of intravitreally injected triamcino-lone acetonide in intraocular silicone oil. Br J Ophthalmol 2002;86:1450-1451. (Pubitemid 35408664)
24. Foster RE, Meyers SM. Recurrent retinal detachment more than 1 year after reattachment. Ophthalmology 2002;109: 1821-1827.
25. Pastor JC. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998;43:3-18. (Pubitemid 28364465)
26. Chaudhry NA, Cohen KA, Flynn HW Jr, Murray TG. Combined pars plana vitrectomy and lens management in complex vitreoretinal disease. Semin Ophthalmol 2003;18: 132-141. (Pubitemid 38404838)
27. Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 2003;121:729-730. (Pubitemid 36554480)
28. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999;27: 431-432. (Pubitemid 30040169)
29. Wesolek-Czernik A. [The influence of silicone oil removal on intraocular pressure]. Klin Oczna 2002;104:219-221.